APA
Tuuminen T., Sorva S., Liippo K., Vasankari T., Soini H., Eriksén-Neuman B., Miettinen A. & Seppälä I. J. (20070904). Feasibility of commercial interferon-gamma-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guérin vaccination coverage. : Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
Chicago
Tuuminen T, Sorva S, Liippo K, Vasankari T, Soini H, Eriksén-Neuman B, Miettinen A and Seppälä I J. 20070904. Feasibility of commercial interferon-gamma-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guérin vaccination coverage. : Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
Harvard
Tuuminen T., Sorva S., Liippo K., Vasankari T., Soini H., Eriksén-Neuman B., Miettinen A. and Seppälä I. J. (20070904). Feasibility of commercial interferon-gamma-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guérin vaccination coverage. : Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
MLA
Tuuminen T, Sorva S, Liippo K, Vasankari T, Soini H, Eriksén-Neuman B, Miettinen A and Seppälä I J. Feasibility of commercial interferon-gamma-based methods for the diagnosis of latent Mycobacterium tuberculosis infection in Finland, a country of low incidence and high bacille Calmette-Guérin vaccination coverage. : Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 20070904.